BridgeMD
Prevention study for Mental Illness
Official title Genetic Counselling in the Prevention of Mental Health Consequences of Cannabis Use
ClinicalTrials.gov ID: NCT03601026
What this study is testing
- What it's testing
- Severe mental illness (SMI) refers to the most burdensome psychiatric conditions. The need to pre-empt the onset of SMI is pressing because once SMI develops, quality of life is poor and available treatments have limited efficacy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 21
You may be able to join if
- Enrolment in the Families Overcoming Risks and Building Opportunities for Well-being (FORBOW) study.
- Age between 12 and 21 years.
- Knowledge of English sufficient to benefit from the intervention.
- Capacity to provide informed consent at most recent FORBOW assessment.
- Provision of consent to be contacted about future studies at most recent FORBOW assessment.
You likely can't join if
- A diagnosis of severe mental illness (psychotic disorder, bipolar disorder, severe/recurrent depression) at baseline
- Autism or intellectual disability of a degree that interferes with assessment (IQ \< 70)
The study team makes the final eligibility decision.
Where it's taking place
- Halifax, Nova Scotia, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 21 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Halifax, Nova Scotia, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.